DCGI Wants Qualified Medical Device Testing Officers

New Delhi:  The Drugs Controller General of India (DCGI) is planning to list the qualification criteria for medical device testing officers.

At present, no qualification is needed, with mostly drugs inspectors deputed to do the job.

This follows increasing complaints by the medical device industry – a market that is estimated to be around $11 billion, and expected to grow to $50 billion by 2030.

The matter was discussed in the Drugs Technical Advisory Board (DTAB) last month, which agreed to amend the Drugs Rules.

At present, the Central or state government, by notification, appoints any person it thinks fit to be Medical Devices Testing Officer who picks samples, tests and evaluates such medical devices.

The medical devices testing officer has the power to propose restricting or allowing the import, manufacture or sale of medical devices – “in public interest”.

“The samples of medical devices cannot be picked up the way drugs are picked up. Devices like MRI or CT Scan machines have to be verified on the site itself for safety features. Therefore, it is very important to depute highly skilled technical officers for the purpose,” said an official aware of the matter.

“There’s an acute shortage of competent medical devices officers at Central Drugs Standard Control Organisation (CDSCO) and State Licensing Authorities from an engineering and science background to adequately regulate medical devices that have recently come under regulations,” Rajiv Nath, forum coordinator, AiMeD (Association of Indian Medical Devices Industry).

Due to these shortages pharmacists and drug inspectors have been redesignated as Medical Devices Officers and in many cases these are not experts at the diverse range of engineered medical devices they are supposed to regulate,” he said.

“This becomes a huge challenge to manufacturers as they struggle to communicate with these regulators who see products like defibrillators and ventilators from the eye of medicine. It’s like an Air Force officer telling a naval officer what’s expected by the Air Force. The government needs to address this staffing and competence urgently if we are aiming India to be the leading manufacturing hub for medical devices globally as stated in the National Medical Devices Policy 2023.”

The government has approached various institutions for designating medical device testing laboratories so that medical devices and in-vitro diagnostic devices available in the market can be tested for safety and performance.

In India, medical devices are a category of almost 5,000 products. Different categories of medical devices may require different kinds of testing infrastructure.

Related Posts

Fujifilm India launches therapeutic endoscopy portfolio at Endocon 2026

Fujifilm India, a leading healthcare technology company, has expanded its ELUXEO 8000 endoscopy portfolio with the launch of its next-generation therapeutic gastroscopes at Endocon 2026. India is witnessing a growing…

Draft bill proposes powers for DIs to inspect online pharmacy office premises

Amidst years of uncertainty over the regulation of e-pharmacies in the country, the draft Drugs, Medical Devices and Cosmetics Bill, 2026, proposes to bestow the powers with the drugs inspectors…

Leave a Reply

Your email address will not be published. Required fields are marked *

You Missed

Fujifilm India launches therapeutic endoscopy portfolio at Endocon 2026

Fujifilm India launches therapeutic endoscopy portfolio at Endocon 2026

Draft bill proposes powers for DIs to inspect online pharmacy office premises

Draft bill proposes powers for DIs to inspect online pharmacy office premises

Argentina committed to reducing barriers to facilitate entry of Indian pharma sector: Government

Argentina committed to reducing barriers to facilitate entry of Indian pharma sector: Government

FDA cancels drug sale licences of Cipla Pharma & Life Sciences’ Pune Carry and Forwarding unit

FDA cancels drug sale licences of Cipla Pharma & Life Sciences’ Pune Carry and Forwarding unit

Delhi DCA mandates digital tracking for controlled substances on new DMS portal

Delhi DCA mandates digital tracking for controlled substances on new DMS portal

How much of Healthcare Research reaches Bedside in India? Or gets Lost in Translation?

How much of Healthcare Research reaches Bedside in India? Or gets Lost in Translation?